Charles R. Kummeth - 15 Aug 2022 Form 4 Insider Report for BIO-TECHNE Corp (TECH)

Role
Chief Executive Officer, Director
Signature
/s/ Brenda S. Furlow, Attorney-in-Fact
Issuer symbol
TECH
Transactions as of
15 Aug 2022
Net transactions value
$0
Form type
4
Filing time
17 Aug 2022, 17:23:01 UTC
Previous filing
09 Aug 2022
Next filing
06 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding TECH Common Stock 240,403 15 Aug 2022 Direct F1
holding TECH Common Stock 100 15 Aug 2022 By Step-Son
holding TECH Common Stock 100 15 Aug 2022 By Step-Daughter

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TECH Restricted Stock Units Award $0 +13,225 $0.000000 13,225 15 Aug 2022 Common Stock 13,225 Direct F3, F4
transaction TECH Stock Options (Right to Buy) Award $0 +300,000 $0.000000 300,000 15 Aug 2022 Common Stock 300,000 $378.08 Direct F5
holding TECH Stock Options (Right to Buy) 256,010 15 Aug 2022 Common Stock 256,010 $106.59 Direct F2
holding TECH Stock Options (Right to Buy) 194,771 15 Aug 2022 Common Stock 194,771 $125.05 Direct F2
holding TECH Stock Options (Right to Buy) 90,334 15 Aug 2022 Common Stock 90,334 $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 60,222 15 Aug 2022 Common Stock 60,222 $177.32 Direct F2
holding TECH Stock Options (Right to Buy) 85,725 15 Aug 2022 Common Stock 85,725 $190.41 Direct F2
holding TECH Stock Options (Right to Buy) 57,150 15 Aug 2022 Common Stock 57,150 $190.41 Direct F6
holding TECH Restricted Stock Units 12,879 15 Aug 2022 Common Stock 12,879 Direct F3, F7
holding TECH Stock Options (Right to Buy) 57,442 15 Aug 2022 Common Stock 57,442 $267.87 Direct F7
holding TECH Stock Options (Right to Buy) 38,295 15 Aug 2022 Common Stock 38,295 $267.87 Direct F8
holding TECH Stock Options (Right to Buy) 16,650 15 Aug 2022 Common Stock 16,650 $267.87 Direct F9
holding TECH Stock Options (Right to Buy) 16,650 15 Aug 2022 Common Stock 16,650 $267.87 Direct F10
holding TECH Restricted Stock Units 8,016 15 Aug 2022 Common Stock 8,016 Direct F3, F11
holding TECH Stock Options (Right to Buy) 31,315 15 Aug 2022 Common Stock 31,315 $481.82 Direct F11
holding TECH Stock Options (Right to Buy) 20,876 15 Aug 2022 Common Stock 20,876 $481.82 Direct F12
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 2,862 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 3,562 shares of restricted stock for which the risk of forfeiture will lapse as to 1,782 shares on each of August 6, 2023 and August 6, 2024.
F2 Fully exercisable.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.
F4 4,408 shares vest on each of 8/15/2023 and 8/15/2025, and 4,409 shares vest on 8/15/2024.
F5 150,000 options vest in full or in part on 7/1/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator), and 150,000 options vest in full or in part on 7/1/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F6 Options to purchase 14,288 shares vest on each of 8/7/2020 and 8/7/2021 and options to purchase 14,287 shares vest on each of 8/7/2022 and 8/7/2023.
F7 Vests in full or in part on 8/5/2023 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F8 Options to purchase 9,573 shares vest on 8/5/21 and options to purchase 9,574 shares vest on each of 8/5/22, 8/5/23 and 8/5/24.
F9 Vests in full on the date performance of certain product revenue goals during the period of fiscal 2021-2023 is certified by the Administrator, in no event earlier than 8/5/2021.
F10 Options to purchase 5,550 shares vest on each of 8/5/21, 8/5/22 and 8/5/23.
F11 Vests in full or in part on 8/6/2024 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F12 Options to purchase 5,219 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.